FDA Approves Generic Lidocaine Ointment


SunGen Pharma, the specialty pharmaceutical company, has received its eighth ANDA approval from the FDA.

SunGen Pharma has received FDA approval for an abbreviated new drug application approval for Lidocaine Ointment USP, 5%. The drug product is used for the production of anesthesia of accessible mucous membranes of the oropharynx.

The product is also used as an anesthetic lubricant for intubation and for the temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin, and insect bites.

Lidocaine has annual sales of about $60 million.


SunGen Pharma receives eighth ANDA approval from US FDA [news release]. Princeton, NJ; October 31, 2019: Globe Newswire. https://www.globenewswire.com/news-release/2019/10/31/1939048/0/en/SunGen-Pharma-Receives-Eighth-ANDA-Approval-from-US-FDA.html. Accessed October 31, 2019.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
3D illustration of heart
Model of a heart
Man experiencing heart pain
3D illustration of heart
© 2023 MJH Life Sciences

All rights reserved.